BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6105071)

  • 1. The release of biologically and immunologically reactive somatostatin from perifused hypothalamic fragments.
    Terry LC; Rorstad OP; Martin JB
    Endocrinology; 1980 Sep; 107(3):794-800. PubMed ID: 6105071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dopamine on immunoreactive growth hormone-releasing factor and somatostatin secretion from rat hypothalamic slices perifused in vitro.
    Kitajima N; Chihara K; Abe H; Okimura Y; Fujii Y; Sato M; Shakutsui S; Watanabe M; Fujita T
    Endocrinology; 1989 Jan; 124(1):69-76. PubMed ID: 2462495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro.
    Richardson SB; Hollander CS; D'Eletto R; Greenleaf PW; Thaw C
    Endocrinology; 1980 Jul; 107(1):122-9. PubMed ID: 6103801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hypothalamic somatostatin release by beta-adrenergic antagonists.
    Richardson SB; Twente S
    Endocrinology; 1990 Feb; 126(2):1043-6. PubMed ID: 1967576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin release from rat hypothalamus in vitro: effects of melatonin and serotonin.
    Richardson SB; Hollander CS; Prasad JA; Hirooka Y
    Endocrinology; 1981 Aug; 109(2):602-6. PubMed ID: 6113952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine stimulates somatostatin release from perifused hypothalamic cells.
    Richardson SB; Nguyen T; Hollander CS
    Am J Physiol; 1983 Jun; 244(6):E560-6. PubMed ID: 6134472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stimulation of somatostatin release by hpGRF44 from rat hypothalamic cells and fragments in vitro.
    Iwasaki K; Fujii A; Merchenthaler I; Groot K; Arimura A
    Tokai J Exp Clin Med; 1987 May; 12(2):117-24. PubMed ID: 2897140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone.
    Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P
    Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of rat hypothalamic somatostatin release by somatostatin: evidence for somatostatin ultrashort loop feedback.
    Richardson SB; Twente S
    Endocrinology; 1986 May; 118(5):2076-82. PubMed ID: 2870911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse hypothalamic somatostatin release: roles of calcium and calmodulin.
    Richardson S; Twente S
    Endocrinology; 1985 Jul; 117(1):369-75. PubMed ID: 2861080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant effects of endogenous and exogenous somatostatin on growth hormone-releasing hormone secretion from perifused mouse hypothalami.
    Pecori Giraldi F; Frohman LA
    Neuroendocrinology; 1995 May; 61(5):566-72. PubMed ID: 7617135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucopenia-mediated release of somatostatin from incubated rat hypothalamus: monosaccharide specificity and role of glycolytic intermediates.
    Berelowitz M; Ting NC; Murray L
    Endocrinology; 1989 Feb; 124(2):826-30. PubMed ID: 2563242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of alterations in the pituitary-thyroid axis on hypothalamic content and in vitro release of somatostatin-like immunoreactivity.
    Berelowitz M; Maeda K; Harris S; Frohman LA
    Endocrinology; 1980 Jul; 107(1):24-9. PubMed ID: 6103803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of somatostatin withdrawal and growth hormone (GH)-releasing factor on GH release in vitro: amount available for release after disinhibition.
    Kraicer J; Cowan JS; Sheppard MS; Lussier B; Moor BC
    Endocrinology; 1986 Nov; 119(5):2047-51. PubMed ID: 2876882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin rapidly restores rat growth hormone (GH) release response attenuated by prior exposure to human GH-releasing factor in vitro.
    Soya H; Suzuki M
    Endocrinology; 1988 Jun; 122(6):2492-8. PubMed ID: 2897284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-induced somatostatin release from perifused rat hypothalamus: calcium dependency and effect of cysteamine treatment.
    Shimatsu A; Kato Y; Matsushita N; Ohta H; Kabayama Y; Imura H
    Neurosci Lett; 1983 Jun; 37(3):285-9. PubMed ID: 6136940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of growth hormone, prolactin and somatostatin during perifusion of anterior pituitary and preoptic-medial basal hypothalamus from male and female rats.
    Critchlow V; Dyke A; Kaler LW
    Brain Res; 1986 Nov; 398(2):347-53. PubMed ID: 2879609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the glucose-dependent release of growth hormone-releasing factor and somatostatin from superfused rat hypothalami.
    Baes M; Vale WW
    Neuroendocrinology; 1990 Feb; 51(2):202-7. PubMed ID: 1968236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of somatostatin and TRH release by rat hypothalamic and cerebral cortical neurons maintained on a capillary membrane perfusion system.
    Scanlon MF; Robbins RJ; Bolaffi JL; Jackson IM; Reichlin S
    Neuroendocrinology; 1983 Oct; 37(4):269-74. PubMed ID: 6138723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.